CTOs on the Move

Bel-Art Products

www.belart.org

 
Bel-Art Products is a Pequannock, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.belart.org
  • 6 Industrial Rd
    Pequannock, NJ USA 07440
  • Phone: 800.423.5278

Executives

Name Title Contact Details

Similar Companies

Christian Care Retirement Comm

Christian Care Retirement Comm is a Bluffton, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CardioGenesis Corporation

CardioGenesis Corporation is a Kennesaw, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hayes Management Consulting

As a trusted advisor to healthcare organizations, Hayes leverages its decades of experience and real world expertise to help clients succeed in a disruptive and evolving healthcare market. From streamlining operations to optimizing systems to developing organizational strategy, Hayes consultants deliver customized services that leave each client fully prepared for success.

DuvaSawko

DuvaSawko is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Daytona Beach, FL. To find more information about DuvaSawko, please visit www.duvasawko.com

PolyNovo Limited

At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.